Miller Fisher syndrome associated with COVID 19.

Yaqoob, Arjimand; Dar, Waseem; Khuja, Zubair; Bukhari, Immia; Raina, Adnan; Ganie, Hilal; Chandra, Amit; Wani, Maqbool; Asimi, Ravouf; Wani, Faizan

Yaqoob, Arjimand; Dar, Waseem; Khuja, Zubair; Bukhari, Immia; Raina, Adnan; Ganie, Hilal; Chandra, Amit; Wani, Maqbool; Asimi, Ravouf; Wani, Faizan.

Afiliación

Yaqoob A; Department of Neurology, SKIMS, Jammu and Kashmir, India.
Dar W; Department of Neurology, SKIMS, Jammu and Kashmir, India.
Khuja Z; Department of Neurology, SKIMS, Jammu and Kashmir, India.
Bukhari I; Department of Neurology, SKIMS, Jammu and Kashmir, India.
Raina A; Department of Neurology, SKIMS, Jammu and Kashmir, India.
Ganie H; Department of Neurology, SKIMS, Jammu and Kashmir, India.
Chandra A; Department of Neurology, SKIMS, Jammu and Kashmir, India.
Wani M; Department of Neurology, SKIMS, Jammu and Kashmir, India.
Asimi R; Department of Neurology, SKIMS, Jammu and Kashmir, India.
Wani F; Department of General Medicine, SKIMS, Jammu and Kashmir, India.

J Family Med Prim Care ; 11(7): 4023-4025, 2022 Jul.

Article en En | MEDLINE | ID: mdl-36387653

Palabras clave

COVID-19; GBS; MFS; SARS-CoV-2

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: J Family Med Prim Care Año: 2022 Tipo del documento: Article País de afiliación: India

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google